Evidence map›Paper›PMID 30996780›Full record

ArticleACS medicinal chemistry letters2019

Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein.

Mattia Mori, Maria Chiara Dasso Lang, Francesco Saladini, Nastasja Palombi, Lesia Kovalenko, Davide De Forni, Barbara Poddesu, Laura Friggeri, Alessia Giannini, Savina Malancona and 4 more

Open access · greenAbstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles.International journal of molecular sciences · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Benzoxaboroles-Novel Autotaxin Inhibitors.Molecules (Basel, Switzerland) · 2019
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Mattia MoriDepartment of Biotechnology, Chemistry and Pharmacy, "Department of Excellence 2018-2022", University of Siena, via Aldo Moro 2, 53100 Siena, Italy.
Maria Chiara Dasso LangDepartment of Biotechnology, Chemistry and Pharmacy, "Department of Excellence 2018-2022", University of Siena, via Aldo Moro 2, 53100 Siena, Italy.
Francesco SaladiniDepartment of Medical Biotechnologies, University of Siena, Viale Mario Bracci, 16, 53100 Siena, Italy.
Nastasja PalombiDepartment of Biotechnology, Chemistry and Pharmacy, "Department of Excellence 2018-2022", University of Siena, via Aldo Moro 2, 53100 Siena, Italy.
Lesia KovalenkoLaboratoire de Bioimagerie et Pathologies, UMR 7021, Faculté de Pharmacie, Université de Strasbourg, CNRS, 74 Route du Rhin, 67401 Illkirch, France.
Davide De ForniViroStatics S.r.l., Viale Umberto I 46, 07100 Sassari, Italy.
Barbara PoddesuViroStatics S.r.l., Viale Umberto I 46, 07100 Sassari, Italy.
Laura FriggeriDepartment of Biotechnology, Chemistry and Pharmacy, "Department of Excellence 2018-2022", University of Siena, via Aldo Moro 2, 53100 Siena, Italy.
Alessia GianniniDepartment of Medical Biotechnologies, University of Siena, Viale Mario Bracci, 16, 53100 Siena, Italy.
Savina MalanconaIRBM Science Park S.p.A., Via Pontina Km 30.600, 00071 Pomezia (RM), Italy.
Vincenzo SummaIRBM Science Park S.p.A., Via Pontina Km 30.600, 00071 Pomezia (RM), Italy.
Maurizio ZazziDepartment of Medical Biotechnologies, University of Siena, Viale Mario Bracci, 16, 53100 Siena, Italy.
Yves MelyLaboratoire de Bioimagerie et Pathologies, UMR 7021, Faculté de Pharmacie, Université de Strasbourg, CNRS, 74 Route du Rhin, 67401 Illkirch, France.
Maurizio BottaDepartment of Biotechnology, Chemistry and Pharmacy, "Department of Excellence 2018-2022", University of Siena, via Aldo Moro 2, 53100 Siena, Italy.
University of Siena · ITCentre National de la Recherche Scientifique · FRIRBM Science Park · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small molecule inhibitors of the HIV-1 nucleocapsid protein (NC) are considered as promising agents in the treatment of HIV/AIDS. In an effort to exploit the privileged 2-amino-4-phenylthiazole moiety in NC inhibition, here we conceived, synthesized, and tested

Identifiers

PMID30996780
PMCPMC6466545
OpenAlexW2905491719

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.